Ca del colon-retto ngc browse Disease/Condition Results




Дата канвертавання24.04.2016
Памер18.59 Kb.

Ca del colon-retto

NGC Browse - Disease/Condition Results


Diseases (MeSH Category) - List all 1098 guidelines

Neoplasms - List all 213 guidelines

Neoplasms by Site - List all 176 guidelines

Digestive System Neoplasms - List all 48 guidelines

Gastrointestinal Neoplasms - List all 35 guidelines

Intestinal Neoplasms - List all 32 guidelines

Colorectal Neoplasms - List all 32 guidelines


  1. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.  American Society of Clinical Oncology - Medical Specialty Society.  1997 (revised 2001 Mar).  14 pages.

  2. ACR Appropriateness Criteria™ for pre-treatment staging of colorectal cancer.  American College of Radiology - Medical Specialty Society.  1996 (revised 1999).  8 pages. 

  3. Management of colorectal cancer. A national clinical guideline.  Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.].  2003 Mar.  47 pages

  4. Preventive health care, 2001 update: colorectal cancer screening.  Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.].  2001.  2 pages.

  5. Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer.  Practice Guidelines Initiative - State/Local Government Agency [Non-U.S.].  2001 Oct 23 (updated online 2003 Feb).  20 pages. 

  6. Use of irinotecan in the treatment of metastatic colorectal carcinoma.  Practice Guidelines Initiative - State/Local Government Agency [Non-U.S.].  1999 Apr 30 (updated online 2000 Apr).

  7. Use of raltitrexed (Tomudex) in the management of metastatic colorectal carcinoma.  Practice Guidelines Initiative - State/Local Government Agency [Non-U.S.].  1998 May 22 (updated online 2003 Feb).

AHRQ Search Results: 1


U.S. Preventive Services Task Force. Colorectal Cancer - Screening July 2002

PNLG Search Results: 0

CMA Search Results: 4


  1. Use of irinotecan (Camptosar®, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer.  Practice Guidelines Initiative - State/Local Government Agency [Non-U.S.].  2001 Oct 23 (updated online 2003 Feb).  20 pages. 

  2. Use of irinotecan in the treatment of metastatic colorectal carcinoma.  Practice Guidelines Initiative - State/Local Government Agency [Non-U.S.].  1999 Apr 30 (updated online 2000 Apr).

  3. Use of raltitrexed (Tomudex) in the management of metastatic colorectal carcinoma.  Practice Guidelines Initiative - State/Local Government Agency [Non-U.S.].  1998 May 22 (updated online 2003 Feb).

  4. Preventive health care, 2001 update: colorectal cancer screening.  Canadian Task Force on Preventive Health Care - National Government Agency [Non-U.S.].  2001.  2 pages.

NeLH Search Results: 5 record


  1. NICE 2000. Guidance on the use of Laparoscopic Surgery for Colorectal Cancer

  2. NICE 2002. Guidance on the use of irinotecan, oxaliplatin & raltitrexed for the treatment of advanced colorectal cancer

  3. SIGN. Management of Colorectal Cancer

  4. NICE 2003. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer

  5. 2002 British gastroenterology society. Colorectal Cancer Screening : Guidelines for follow up after resection of colorectal cancer

SIGN search: 1


SIGN. Management of Colorectal Cancer

New Zealand Search Results: 0

Cochrane search: 3 records


  1. Screening for colorectal cancer using the faecal occult blood test, Hemoccult (Cochrane Review)

  2. Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane Review)

  3. Palliative chemotherapy for advanced or metastatic colorectal cancer (Cochrane Review)

  4. Curative Surgery for Obstruction from Primary Left Colorectal Carcinoma: Primary or Staged Resection? (Cochrane Review)

  5. Stapled versus handsewn methods for colorectal anastomosis surgery (Cochrane Review)

  6. Mechanical bowel preparation for elective colorectal surgery (Cochrane Review)

  7. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver (Cochrane Review)

  8. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery (Cochrane Review)



CRD Databases search: 15 records


  1. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. Renehan A G, O'Dwyer S T, Whynes D K. BMJ 2004;328:81.

  2. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. Renehan A G, Egger M, Saunders M P, O'Dwyer S T. BMJ 2002; 324: 813-816.

  3. Should the MUHC approve the use of colorectal stents?. McGregor M. Technology Assessment Unit of the McGill University Health Centre (MUHC) 2003: 13.

  4. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. National Institute for Clinical Excellence. National Institute for Clinical Excellence (NICE) 2003 (Technology Appraisal Guidance - No.61): 25.

  5. Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review (French). Selke B, Lebrun T, Comte S. Bulletin du Cancer 2003;90(2):143-149.

  6. G17DT for stomach, pancreatic and colorectal cancer - horizon scanning review. National Horizon Scanning Centre. National Horizon Scanning Centre (NHSC) 2003.

  7. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. Ward S, Kaltenthaler E, Cowen J, Brewer N. Health Technology Assessment Vol.7: No.32 2003: 106.

  8. Health technology assessment of positron emission tomography in oncology - a systematic review. Institute for Clinical Evaluative Sciences (ICES) 2003: 21.

  9. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS)) 2002 (Understanding HTBS Advice): 10.

  10. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Lloyd Jones M, Hummel S, Bansback N, Orr B, Seymour M. Health Technology Assessment 2002; 5(25): 1-128.

  11. Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer. Cunningham D, Falk S, Jackson D. British Journal of Cancer 2002;86(11):1677-1683.

  12. Cetuximab for head and neck and colorectal cancer. National Horizon Scanning Centre. National Horizon Scanning Centre (NHSC) 2002 (New and Emerging Technology Briefing): 5.

  13. Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer. Hale J P, Cohen D R, Maughan T S, Stephens R J. British Journal of Cancer 2002;86(11):1684-1690.

  14. Computed tomographic colonography (virtual colonoscopy). Health Technology Advisory Committee. Health Technology Advisory Committee (HTAC) 2002.

  15. Scoring systems for assessing postoperative risk in colorectal surgery. Bernath V. Centre for Clinical Effectiveness (CCE) 2002 (Evidence Centre Evidence Report): 8.


База данных защищена авторским правом ©shkola.of.by 2016
звярнуцца да адміністрацыі

    Галоўная старонка